Treatment Groups | Total \({\bf{NO}}_2^ - \) and \({\bf{NO}}_3^ - \) (pmol/mg/24 hr) | p Value a (ANOVA) | cGMP (fmol/mg/24 hr) | p Value ‡ (ANOVA) |
---|---|---|---|---|
Control | 29.7 ± 6.5b | — | 5.2 ± 2.8 | — |
Injury alone | 35.4 ± 8.4 | NSC | 7.3 ± 3.4 | NS |
Injury + MFGlacZ | 40.1 ± 5.2 | NS | 6.8 ± 2.9 | NS |
Injury + DFGiNOS | 121.9 ± 43.1 | 0.001 | 101.3 ± 12.1 | 0.002 |
Injury + DFGiNOS + L-NMA | 37.4 ± 8.2 | NS | 5.6 ± 4.2 | NS |